This is a biopharmaceutical company developing drug candidates with a focus on the treatment of pain and inflammation. This stock is up 7.9%, to $1.15 in recent trading.
Today's Range: $1.07-$1.16
52-week Range: $0.72-$2.90
Three-Month Average Volume: 1,655,760
From a technical perspective, ZLCS is skyrocketing here, back above its 200-day moving average of $1.10 with monster volume. This move has also pushed the stock within range of triggering a near-term breakout trade. That trade will hit once ZLCS takes out some near-term overhead resistance at $1.14 with high volume.
Traders should continue to look for long-biased trades as long as ZLCS is trending above its 200-day, and if it can sustain a high-volume move or close over $1.14. Look for volume on that move that's near or above 1,655,760 shares. If we get that action soon, then look for ZLCS to tag its March high of $1.34 or possibly trend much higher.
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts